Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janell Routh is active.

Publication


Featured researches published by Janell Routh.


Emerging Infectious Diseases | 2011

Risk Factors Early in the 2010 Cholera Epidemic, Haiti

Katherine O’Connor; Emily J. Cartwright; Anagha Loharikar; Janell Routh; Joanna Gaines; Marie-Délivrance Bernadette Fouché; Reginald Jean-Louis; Tracy Ayers; Dawn Johnson; Jordan W. Tappero; Thierry H. Roels; W. Roodly Archer; Georges Dahourou; Eric D. Mintz; Robert Quick; Barbara E. Mahon

During the early weeks of the cholera outbreak that began in Haiti in October 2010, we conducted a case–control study to identify risk factors. Drinking treated water was strongly protective against illness. Our results highlight the effectiveness of safe water in cholera control.


PLOS Neglected Tropical Diseases | 2014

Shifts in Geographic Distribution and Antimicrobial Resistance during a Prolonged Typhoid Fever Outbreak — Bundibugyo and Kasese Districts, Uganda, 2009–2011

Maroya Spalding Walters; Janell Routh; Matthew Mikoleit; Samuel Kadivane; Caroline Ouma; Denis Mubiru; Ben Mbusa; Amos Murangi; Emmanuel Ejoku; Absalom Rwantangle; Uziah Kule; John Lule; Nancy M. Garrett; Jessica L. Halpin; Nikki Maxwell; Atek Kagirita; Fred Mulabya; Issa Makumbi; Molly M. Freeman; Kevin Joyce; Vince Hill; Robert Downing; Eric D. Mintz

Background Salmonella enterica serovar Typhi is transmitted by fecally contaminated food and water and causes approximately 22 million typhoid fever infections worldwide each year. Most cases occur in developing countries, where approximately 4% of patients develop intestinal perforation (IP). In Kasese District, Uganda, a typhoid fever outbreak notable for a high IP rate began in 2008. We report that this outbreak continued through 2011, when it spread to the neighboring district of Bundibugyo. Methodology/Principal Findings A suspected typhoid fever case was defined as IP or symptoms of fever, abdominal pain, and ≥1 of the following: gastrointestinal disruptions, body weakness, joint pain, headache, clinically suspected IP, or non-responsiveness to antimalarial medications. Cases were identified retrospectively via medical record reviews and prospectively through laboratory-enhanced case finding. Among Kasese residents, 709 cases were identified from August 1, 2009–December 31, 2011; of these, 149 were identified during the prospective period beginning November 1, 2011. Among Bundibugyo residents, 333 cases were identified from January 1–December 31, 2011, including 128 cases identified during the prospective period beginning October 28, 2011. IP was reported for 507 (82%) and 59 (20%) of Kasese and Bundibugyo cases, respectively. Blood and stool cultures performed for 154 patients during the prospective period yielded isolates from 24 (16%) patients. Three pulsed-field gel electrophoresis pattern combinations, including one observed in a Kasese isolate in 2009, were shared among Kasese and Bundibugyo isolates. Antimicrobial susceptibility was assessed for 18 isolates; among these 15 (83%) were multidrug-resistant (MDR), compared to 5% of 2009 isolates. Conclusions/Significance Molecular and epidemiological evidence suggest that during a prolonged outbreak, typhoid spread from Kasese to Bundibugyo. MDR strains became prevalent. Lasting interventions, such as typhoid vaccination and improvements in drinking water infrastructure, should be considered to minimize the risk of prolonged outbreaks in the future.


Emerging Infectious Diseases | 2011

Rapid Assessment of Cholera-related Deaths, Artibonite Department, Haiti, 2010

Janell Routh; Anagha Loharikar; Marie-Délivrance Bernadette Fouché; Emily J. Cartwright; Sharon L. Roy; Elizabeth Ailes; W. Roodly Archer; Jordan W. Tappero; Thierry H. Roels; Georges Dahourou; Robert Quick

We evaluated a high (6%) cholera case-fatality rate in Haiti. Of 39 community decedents, only 23% consumed oral rehydration salts at home, and 59% did not seek care, whereas 54% of 48 health facility decedents died after overnight admission. Early in the cholera epidemic, care was inadequate or nonexistent.


Infectious Diseases in Obstetrics & Gynecology | 2015

Estimating the Attack Rate of Pregnancy-Associated Listeriosis during a Large Outbreak

Maho Imanishi; Janell Routh; Marigny Klaber; Weidong Gu; Michelle S. Vanselow; Kelly A. Jackson; Loretta Sullivan-Chang; Gretchen A Heinrichs; Neena S. Jain; Bernadette A Albanese; William M. Callaghan; Barbara E. Mahon; Benjamin J. Silk

Background. In 2011, a multistate outbreak of listeriosis linked to contaminated cantaloupes raised concerns that many pregnant women might have been exposed to Listeria monocytogenes. Listeriosis during pregnancy can cause fetal death, premature delivery, and neonatal sepsis and meningitis. Little information is available to guide healthcare providers who care for asymptomatic pregnant women with suspected L. monocytogenes exposure. Methods. We tracked pregnancy-associated listeriosis cases using reportable diseases surveillance and enhanced surveillance for fetal death using vital records and inpatient fetal deaths data in Colorado. We surveyed 1,060 pregnant women about symptoms and exposures. We developed three methods to estimate how many pregnant women in Colorado ate the implicated cantaloupes, and we calculated attack rates. Results. One laboratory-confirmed case of listeriosis was associated with pregnancy. The fetal death rate did not increase significantly compared to preoutbreak periods. Approximately 6,500–12,000 pregnant women in Colorado might have eaten the contaminated cantaloupes, an attack rate of ~1 per 10,000 exposed pregnant women. Conclusions. Despite many exposures, the risk of pregnancy-associated listeriosis was low. Our methods for estimating attack rates may help during future outbreaks and product recalls. Our findings offer relevant considerations for management of asymptomatic pregnant women with possible L. monocytogenes exposure.


Morbidity and Mortality Weekly Report | 2017

Acute Flaccid Myelitis Among Children - Washington, September-November 2016.

Jesse Bonwitt; Amy Poel; Chas DeBolt; Elysia Gonzales; Adriana S. Lopez; Janell Routh; Krista Rietberg; Natalie Linton; James Reggin; James J. Sejvar; Scott Lindquist; Catherine Otten

In October 2016, Seattle Childrens Hospital notified the Washington State Department of Health (DOH) and CDC of a cluster of acute onset of limb weakness in children aged ≤14 years. All patients had distinctive spinal lesions largely restricted to gray matter detected by magnetic resonance imaging (MRI), consistent with acute flaccid myelitis (AFM). On November 3, DOH issued a health advisory to local health jurisdictions requesting that health care providers report similar cases. By January 24, 2017, DOH and CDC had confirmed 10 cases of AFM and excluded two suspected cases among residents of Washington during September-November 2016. Upper respiratory tract, stool, rectal, serum, buccal, and cerebrospinal fluid (CSF) specimens were tested for multiple pathogens. Hypothesis-generating interviews were conducted with patients or their parents to determine commonalities between cases. No common etiology or source of exposure was identified. Polymerase chain reaction (PCR) testing detected enterovirus D68 (EV-D68) in nasopharyngeal swabs of two patients, one of whom also tested positive for adenovirus by PCR, and detected enterovirus A71 (EV-A71) in the stool of a third patient. Mycoplasma spp. immunoglobulin M (IgM) titer was elevated in two patients, but both had upper respiratory swabs that tested negative for Mycoplasma spp. by PCR. Clinicians should maintain vigilance for AFM and report cases as soon as possible to state or local health departments.


Morbidity and Mortality Weekly Report | 2017

Notes from the Field: Cluster of Acute Flaccid Myelitis in Five Pediatric Patients — Maricopa County, Arizona, 2016

Sally Ann Iverson; Scott Ostdiek; Siru Prasai; David M. Engelthaler; Melissa Kretschmer; Nicole Fowle; Harlori K. Tokhie; Janell Routh; James J. Sejvar; Tracy Ayers; Jolene Bowers; Shane Brady; Shannon Rogers; W. Allan Nix; Ken Komatsu; Rebecca Sunenshine; Tammy Sylvester; Veronica Harrison; Jennifer Heim; Susan Robinson; Gholamabbas A. Ostovar; Kathryn Fitzpatrick

Cluster of Acute Flaccid Myelitis in Five Pediatric Patients — Maricopa County, Arizona, 2016 Sally A. Iverson, DVM1,2,3; Scott Ostdiek, MD4; Siru Prasai, MD2; David M. Engelthaler, PhD5; Melissa Kretschmer, MA2; Nicole Fowle2; Harlori K. Tokhie, MD4; Janell Routh, MD6; James Sejvar, MD7; Tracy Ayers, PhD6; Jolene Bowers, PhD5; Shane Brady, MPH3; Shannon Rogers, MS6; W. Allan Nix, PhD6; Ken Komatsu, MPH3; Rebecca Sunenshine, MD2,8; AFM Investigation Team


American Journal of Tropical Medicine and Hygiene | 2017

Cost Evaluation of a Government-Conducted Oral Cholera Vaccination Campaign—Haiti, 2013

Joseph D Njau; Eric D. Mintz; Bishwa B. Adhikari; Taiwo Abimbola; Mark A. Katz; Nandini Sreenivasan; Martin I. Meltzer; Rania A. Tohme; Janell Routh; Jeannot François; Stanley Juin; Margarette Bernateau; Ernsley Jackson; Lesly L. Andrecy

Abstract. The devastating 2010 cholera epidemic in Haiti prompted the government to introduce oral cholera vaccine (OCV) in two high-risk areas of Haiti. We evaluated the direct costs associated with the government’s first vaccine campaign implemented in August–September 2013. We analyzed data for major cost categories and assessed the efficiency of available campaign resources to vaccinate the target population. For a target population of 107,906 persons, campaign costs totaled


Morbidity and Mortality Weekly Report | 2017

Notes from the Field: Absence of Asymptomatic Mumps Virus Shedding Among Vaccinated College Students During a Mumps Outbreak — Washington, February–June 2017

Jesse Bonwitt; Vance Kawakami; Adam Wharton; Rachel M. Burke; Neil Murthy; Adria Lee; BreeAnna Dell; Meagan Kay; Jeff Duchin; Carole J. Hickman; Rebecca J. McNall; Paul A. Rota; Manisha Patel; Scott Lindquist; Chas DeBolt; Janell Routh

624,000 and 215,295 OCV doses were dispensed. The total vaccine and operational cost was


BMC Public Health | 2017

A large and persistent outbreak of typhoid fever caused by consuming contaminated water and street-vended beverages: Kampala, Uganda, January - June 2015.

Steven Ndugwa Kabwama; Lilian Bulage; Fred Nsubuga; Gerald Pande; David Were Oguttu; Richardson Mafigiri; Christine Kihembo; Benon Kwesiga; Ben Masiira; Allen Eva Okullo; Henry Kajumbula; Joseph K. B. Matovu; Issa Makumbi; Milton Wetaka; Sam Kasozi; Simon Kyazze; Melissa Dahlke; Peter Hughes; Juliet Nsimire Sendagala; Monica Musenero; Immaculate Nabukenya; Vincent R. Hill; Eric D. Mintz; Janell Routh; Gerardo A. Gómez; Amelia Bicknese; Bao-Ping Zhu

2.90 per dose; vaccine alone cost


Open Forum Infectious Diseases | 2017

Mumps, 2016: A National Overview

Nakia Clemmons; Adria Lee; Susan B. Redd; Janell Routh; Manisha Patel

1.85 per dose, vaccine delivery and administration

Collaboration


Dive into the Janell Routh's collaboration.

Top Co-Authors

Avatar

Eric D. Mintz

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Tracy Ayers

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Anagha Loharikar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Robert Quick

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Adria Lee

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

James J. Sejvar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Manisha Patel

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Adriana S. Lopez

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Bao-Ping Zhu

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Barbara E. Mahon

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge